PROCEPT BioRobotics Corp. (PRCT)
18.15
+0.64
(+3.66%)
USD |
NASDAQ |
Oct 15, 16:00
18.14
-0.01
(-0.06%)
After-Hours: 20:00
PROCEPT BioRobotics Cash from Operations (TTM) : -74.34M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -74.34M |
| March 31, 2026 | -70.13M |
| December 31, 2025 | -48.98M |
| September 30, 2025 | -71.05M |
| June 30, 2025 | -83.21M |
| March 31, 2025 | -83.91M |
| December 31, 2024 | -99.21M |
| September 30, 2024 | -91.62M |
| Date | Value |
|---|---|
| June 30, 2024 | -91.76M |
| March 31, 2024 | -104.36M |
| December 31, 2023 | -108.00M |
| September 30, 2023 | -108.38M |
| June 30, 2023 | -109.29M |
| March 31, 2023 | -98.08M |
| December 31, 2022 | -80.38M |
| September 30, 2022 | -71.68M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Insulet Corp. | 511.30M |
| Abbott Laboratories | 9.905B |
| Globus Medical, Inc. | 910.39M |
| Stryker Corp. | 5.525B |
| Baxter International, Inc. | 1.319B |